Bio-Pharmaceuticals Industry In India (2018-2023) with data Biotechnology Market and Pharmaceutical Company Information (Cipla, Lupin, Sun Pharma, Aurobindo Pharma and Dr Reddys Labs)
Bio-pharmaceutical products are manufactured in the form of complex macromolecules developed through genetic manipulation of living organisms using gene cloning, recombination of DNA and cell fusion. The biotechnology industry comprises bio-pharmaceuticals, bio-agriculture, bio-informatics, bio-services, and bio-industry.
Bio-pharmaceuticals Industry in India (2018-2023)
The bio-pharmaceuticals market in India is expected to reach a value of INR 2,891.70 Bn in FY 2023, expanding at a compound annual growth rate (CAGR) of ~31.7% since FY 2018. India caters to nearly 50% of the global demand for pharmaceutical products, most of which are based on the usage of biotechnological applications. Currently, bio-pharmaceuticals is one of the fastest growing biotechnology segments in India. The significant bio-pharmaceutical clusters of India are located in Haridwar, Sikkim, Hyderabad, Vishakhapatnam, Chennai, Pondicherry, Mysore, Mumbai, Ahmedabad, and Delhi NCR.
Government initiatives and investments:
The major investors in the Indian bio-pharmaceutical market are AstraZeneca, Johnson & Johnson, GlaxoSmithKline (GSK), Nipro and Otsuka. In 2017, 46 mergers and acquisition (M&A) deals were signed in the Indian bio-pharmaceutical market, generating business worth INR 94.77 Bn. The Indian government has taken the initiative to set up an electronic platform for regulating online pharmacies. ‘Pharma Vision 2020’ has been unveiled so that India can emerge as a global leader in terms of end-to-end drug manufacturing.
Key growth drivers of the market:
India comprises of ~0.13 Mn highly skilled and experienced scientists who serve as a strong support system for the business process of the bio-pharmaceutical industry. With the help of the educational qualifications and skillset of these people, India is considered to be a significant center for bio-pharmaceutical research and development (R&D), especially for vaccine manufacturing.
The Government of India has approved an investment of INR 15,000 Mn under the Innovate in India (i3) program, for collaboration of industrial organizations and academic organizations over the next five years. This program is considered to act as a significant action of the Government in its way of boosting bio-pharmaceutical production in the country.
Key deterrents to the growth of the market:
It often takes a long time for the manufacturing companies to launch a new market-ready bio-pharmaceutical product in India due to the existence of numerous regulatory challenges in the process.
Also, the Indian bio-pharmaceutical industry lacks proper infrastructure regarding limited government-sponsored laboratory space, consumables, chemical components, and equipment, which acts as a significant hindrance to the growth of the market.
Cadila Healthcare Ltd.
Dr. Reddy’s Laboratories Ltd.
Panacea Biotec Ltd.
GSK Pharmaceuticals Ltd.
Bharat Biotech International Ltd.
Bharat Serums and Vaccines Ltd.
Indian Immunologicals Ltd.
Serum Institute of India Pvt. Ltd.
Frequently Asked Questions For Asia Bio-Pharmaceuticals Industry Market
Which Marketing Strategies are Being Adopted by the Top Key Players of the Asia Bio-Pharmaceuticals Industry Market?
This Asia Bio-Pharmaceuticals Industry Market Research Report is Designed To Aid Businessmen/Investors to Analyse The Best Marketing Tactics For Any Business Situation. It Suggests Proven And Most Effective Marketing Strategies Being Adopted By The Top Key Players For Business Growth. Also, The Research Team has Carried Out Market Study, Research, and Analysis of The Global Top Leading Companies to Comprehend What Makes Them Stand Out From The Crowd. The report includes effective marketing channels, keyword distributors list, and customer details of the Asia Bio-Pharmaceuticals Industry market.
What Drivers And Restraints are Shaping The Growth of the Asia Bio-Pharmaceuticals Industry Market?
It is Essential for Businessmen to Understand Both the Driving Factors and The Restraining Forces of the Industry. Hence, the Report Comprises In-Depth Information About the Drivers And Restraints That Helps Businessmen To Identify The Opportunistic Business Potential.
Which Segment or Region Will Lead the Asia Bio-Pharmaceuticals Industry Market?
The Report Exhibits Region/Segment Analysis That Propels the Growth of the Industry. It Covers All the Regions, Key Developed Nations and Major Emerging Industries. Additionally, it Gives an Outline of The Size of The Industry by Geography and Compares its Forecast Growth.
What are the Upcoming New Projects in the Asia Bio-Pharmaceuticals Industry Market?
This Asia Bio-Pharmaceuticals Industry Market Research Report Would Provide Insights into The New Project Investment Feasibility Analysis Coupled with SWOT Analysis, Project Investment, Project Name, Investment Budget, Project Product Solutions, and Project Schedule.